Some Vaccine Doses Kept Too Cold, Pfizer Having Manufacturing Issues, US Officials Say
The first days of Pfizer Inc’s Covid-19 vaccine rollout have seen unexpected hitches including some vaccines being stored at excessively cold temperatures and Pfizer reporting potential challenges in its vaccine